IL6 and hepatocellular carcinoma: This is further supported by experiments in mice overexpressing the IL-6 trans-signaling inhibitor sgp130Fc, which show reduced tumor formation in the diethylnitrosamine/3,3′,5,5′-tetrachloro-1,4-bis(pyridyloxy)benzene model of HCC [85].